Literature DB >> 35119105

Stress reveals a specific behavioral phenotype for opioid abuse susceptibility.

Chris O'Brien1, Roshni Vemireddy1, Uzma Mohammed1, David J Barker1,2.   

Abstract

Susceptibility to stress has long been considered important for the development of substance use disorders. Nonetheless, behavioral and physiological responses to stress are highly variable, making it difficult to identify the individuals who are most likely to abuse drugs. In the present study, we employed a comprehensive battery of tests for negative valence behaviors and nociception to identify individuals predisposed to opioid seeking following oral opioid self-administration. Furthermore, we examined how this profile was affected by a history of stress. We observed that mice receiving foot shock stress failed to exhibit a preference for sucrose, showed increased immobility in the forced swim task, and exhibited mechanical hypersensitivity when compared to controls. When considering these behaviors in light of future fentanyl-seeking responses, we observed that heightened mechanical sensitivity corresponded to higher opioid preference in mice with a history of stress, but not controls. Moreover, we were surprised to discover that paradoxically high sucrose preferences predicted fentanyl preference in shock mice, while signs of anhedonia predicted fentanyl preference in controls. Taken together, these results indicate that stress can act as a physiological modulator, shifting profiles of opioid abuse susceptibility depending on an individual's history.
© 2022 Society for the Experimental Analysis of Behavior.

Entities:  

Keywords:  anxiety; depression; pain; stress; substance use disorder

Mesh:

Substances:

Year:  2022        PMID: 35119105      PMCID: PMC9090955          DOI: 10.1002/jeab.738

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.215


  56 in total

Review 1.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

2.  Exposure to mild stress enhances the reinforcing efficacy of intravenous heroin self-administration in rats.

Authors:  Y Shaham; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

3.  Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions.

Authors:  P Simon; R Dupuis; J Costentin
Journal:  Behav Brain Res       Date:  1994-03-31       Impact factor: 3.332

4.  The protective effects of voluntary exercise against the behavioral consequences of uncontrollable stress persist despite an increase in anxiety following forced cessation of exercise.

Authors:  Benjamin N Greenwood; Alice B Loughridge; Nouara Sadaoui; John P Christianson; Monika Fleshner
Journal:  Behav Brain Res       Date:  2012-05-17       Impact factor: 3.332

5.  Lower brainstem pathways regulating sympathetically mediated changes in cutaneous blood flow.

Authors:  W W Blessing
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

6.  Behavioral despair in mice: a primary screening test for antidepressants.

Authors:  R D Porsolt; A Bertin; M Jalfre
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-10

Review 7.  The molecular neurobiology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Nature       Date:  2008-10-16       Impact factor: 49.962

8.  Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence.

Authors:  Carlo Colantuoni; Pedro Rada; Joseph McCarthy; Caroline Patten; Nicole M Avena; Andrew Chadeayne; Bartley G Hoebel
Journal:  Obes Res       Date:  2002-06

9.  Formulations of fentanyl for the management of pain.

Authors:  Sina Grape; Stephan A Schug; Stefan Lauer; Barbara S Schug
Journal:  Drugs       Date:  2010       Impact factor: 9.546

10.  Aversion-resistant fentanyl self-administration in mice.

Authors:  Sean C Monroe; Anna K Radke
Journal:  Psychopharmacology (Berl)       Date:  2020-11-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.